![](/img/cover-not-exists.png)
2504 Genomic predictive and prognostic factors from plasma cell-free DNA (cfDNA) for metastatic castration-resistant prostate cancer (mCRPC) patients (pts) commencing enzalutamide (ENZ)
Chi, K., Azad, A., Volik, S., Haegert, A., Zalcberg, J., Le Bihan, S., McConeghy, B., Gleave, M., Wyatt, A., Collins, C.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31326-0
Date:
September, 2015
File:
PDF, 73 KB
english, 2015